Fecal Fn appears more promising for diagnosis/screening than for prognosis: population-based and multicenter studies show improved CRC discrimination using Fn (±Parvimonas micra, Peptostreptococcus) in stool-based panels [34,53]. This evidence concerns the gene FN1 and colorectal carcinoma.